COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,678 Articles (22,913 medRxiv, 8,765 bioRxiv)

Most recent first Previous |  Page 714: Articles 7131-7140  | Next

SARS-CoV-2 viral clearance and viral load kinetics in young children (1-6 years) compared to adults: Results of a longitudinal study in Germany
Sandoni, A. E., Schaffrath Rosario, A., Michel, J., Kuttig, T., Wurm, J., Damerow, S., Iwanowski, H., Finkel, B., Schrick, L., Buchholz, U., Haas, W., Varnaccia, G., Kubisch, U., Jordan, S., Schienkiewitz, A., Nitsche, A., Loss, J.
10.1101/2022.08.09.22278540 — Posted: 2022-08-10
Efficacy and safety of convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized clinical trial
Lacombe, K., Hueso, T., Porcher, R., Mekinian, A., Chiarabini, T., Georgin-Lavialle, S., Ader, F., Saison, J., Martin-Blondet, G., De Castro, N. A., Bonnet, F., Cazanave, C., Francois, A., Morel, P., Hermine, O., Pourcher, V., Michel, M., Lescure, X., Soussi, N., Brun, P., Pommeret, F., Sellier, P., Rousset, S., Piroth, L., Michot, J.-M., baron, g., de Lamballerie, X., Mariette, X., Tharaux, P.-L., Resche-Rigaux, M., Ravaud, P., Simon, T., Tiberghien, P.
10.1101/2022.08.09.22278329 — Posted: 2022-08-10
Brief Report: Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine
Mwimanzi, F. M., Lapointe, H. R., Cheung, P. K., Sang, Y., Yaseen, F., Kalikawe, R., Datwani, S., Burns, L., Young, L., Leung, V., Ennis, S., Brumme, C. J., Montaner, J. S. G., Prystajecky, N., Lowe, C. F. J., DeMarco, M. L., Holmes, D. T., Simons, J., Niikura, M., Romney, M. G., Brumme, Z. L., Brockman, M. A.
10.1101/2022.08.08.22278494 — Posted: 2022-08-10
National Health Insurance Coverage and COVID-19 vaccine acceptance in Uganda. Implications on Uganda's achievement of Universal Healthcare Coverage and Sustainable Development Goals.
Kitara, D. L., Aloyo, J., Oyat, F. W. D., Obalim, L., Ikoona, E. N.
10.1101/2022.08.09.22278595 — Posted: 2022-08-10
Distinguishing features of Long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J., Lu, P., Dhodapkar, R. M., Gehlhausen, J. R., Tabachnikova, A., Tabacof, L., Malik, A. A., Kamath, K., Greene, K., Silva Monteiro, V., Pena-Hernandez, M., Mao, T., Bhattacharjee, B., Takahashi, T., Lucas, C., Silva, J., Mccarthy, D., Breyman, E., Tosto-Mancuso, J., Dai, Y., Perotti, E., Akduman, K., Tzeng, T., Xu, L., Yildirim, I., Krumholz, H. M., Shon, J., Medzhitov, R., Omer, S. B., van Dijk, D., Ring, A. M., Putrino, D., Iwasaki, A.
10.1101/2022.08.09.22278592 — Posted: 2022-08-10
Procalcitonin and High APACHE Scores are Associated with the Development of Acute Kidney Injury in Patients with SARS-CoV-2
Andrade-Sierra, J., Delgado Astorga, C., Nava Vargas, M. G., Rojas Campos, E., Hernandez Morales, K., Andrade Castellanos, C. A., Arellano Arteaga, K. J., Andrade-Ortega, A. d. J., Gonzalez-Correa, L. G.
10.1101/2022.08.09.22274874 — Posted: 2022-08-10
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination
Schaefer-Babajew, D., Wang, Z., Muecksch, F., Cho, A., Raspe, R., Johnson, B., Canis, M., DaSilva, J., Ramos, V., Turroja, M., Millard, K., Schmidt, F., Dizon, J., Shimeliovich, I., Yao, K.-H., Oliveira, T., Gazumyan, A., Gaebler, C., Bieniasz, P. D., Hatziioannou, T., Caskey, M., Nussenzweig, M. C.
10.1101/2022.08.05.22278483 — Posted: 2022-08-10
Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: a real world, retrospective cohort study
Segala, F. V., Rando, E., Salvati, F., Negri, M., Catania, F., Sanmartin, F., Murri, R., Giamarellos-Bourboulis, E. J., Fantoni, M.
10.1101/2022.08.05.22278477 — Posted: 2022-08-10
Impact of Lifting School Masking Requirements on Incidence of COVID-19 among Staff and Students in Greater-Boston Area School Districts: A Difference-in-Differences Analysis
Cowger, T. L., Clarke, J., Murray, E. J., Sanchez, S. M., Bassett, M. T., Ojikutu, B. O., Linos, N., Hall, K. T.
10.1101/2022.08.09.22278385 — Posted: 2022-08-09
Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection
Demko, Z. O., Yu, T., Mullapudi, S. K., Varela Heslin, M. G., Dorsey, C. A., Payton, C. B., Tornheim, J. A., Blair, P. W., Mehta, S. H., Thomas, D. L., Manabe, Y. C., Antar, A. A. R., The OutSMART Study Team
10.1101/2022.08.08.22278543 — Posted: 2022-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).